Back

Cardiac Tc99m-Pyrophosphate uptake may present variable correlation with transthyretin cardiac amyloidosis severity depending on the genotype

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: New insights into diagnosis of cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Marcus Simoes

Medical School of Ribeirao Preto, Ribeirao Preto (Brazil)

7 More presentations in this session

Presentation thumbnail
Diverse anatomical and metabolic effects of amyloid deposits in transthyretin cardiac amyloidosis revealed by 3D reconstruction of serial block face-scanning electron microscopy images
Doctor S. Saito (Shimotsuke, JP)
Abstract Slides
Presentation thumbnail
Trajectory and prognostic significance of conduction system disease in cardiac transthyretin amyloidosis: a european multicenter cohort study
Doctor L. Schlender (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Targeted screening for transthyretin cardiac amyloidosis in severe aortic stenosis: development and validation of a clinical risk score
Assistant Professor A. Antonopoulos (Athens, GR)
Abstract Slides
Presentation thumbnail
Prognostic implications of Perugini Grading in a contemporary centre referral cohort undergoing evaluation for suspected cardiac amyloidosis
Ms N. Hartvig Jensen (DK)
Abstract Slides
Presentation thumbnail
Multimodal assessment of disease progression risk among transthyretin amyloid cardiomyopathy patients under disease-modifying therapy
Doctor J. Groeschel (Berlin, DE)
Abstract Slides

Access the full session

Session thumbnail
New insights into diagnosis of cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction
1 July 2021
thumbnail
Congress Presentation
NT-proBNP and cardiopulmonary exercise testing parameters for risk stratification in ATTR-CM
5 April 2025
thumbnail
Congress Session
The advancing management of transthyretin amyloidosis: a practical guide
26 August 2023
thumbnail
Congress Presentation
Concordance in nuclear imaging test findings in patients with left ventricular hypertrophy screened for transthyretin amyloid cardiomyopathy in the TTRACK study
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources